Pharmabiz

BridgeBio Oncology announces new preclinical data of BBO-11818 demonstrating its potential as a potent panKRAS inhibitor targeting mutant KRAS

South San Francisco, California Saturday, October 25, 2025, 14:00 Hrs [IST] ...
Le Lézard

Bristol Myers Squibb Presents Encouraging Data from Phase 1 Breakfree-1 Study of CD19 NEX-Ttm CAR T Cell Therapy in Three Chronic Autoimmune Diseases at ACR Convergence 2025

Bristol Myers Squibb today announced updated data and first disclosure of results in chronic, refractory autoimmune diseases from the Phase 1 Breakfree-1 study (NCT05869955) of its investigational, ...

Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting

(Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the poster presentation of ...